KR900009624A - 황-함유 헤테로 고리 화합물 - Google Patents
황-함유 헤테로 고리 화합물 Download PDFInfo
- Publication number
- KR900009624A KR900009624A KR1019890019906A KR890019906A KR900009624A KR 900009624 A KR900009624 A KR 900009624A KR 1019890019906 A KR1019890019906 A KR 1019890019906A KR 890019906 A KR890019906 A KR 890019906A KR 900009624 A KR900009624 A KR 900009624A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- compound
- substitutable
- hydrogen atom
- ring
- Prior art date
Links
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title claims abstract 6
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims abstract 6
- 229910052717 sulfur Inorganic materials 0.000 title claims abstract 6
- 239000011593 sulfur Substances 0.000 title claims abstract 6
- 150000001875 compounds Chemical class 0.000 claims abstract 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 10
- 150000003839 salts Chemical class 0.000 claims abstract 9
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 5
- 208000001132 Osteoporosis Diseases 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 3
- -1 6-cyclohexyl-N- (4-diethoxyphosphorylmethylphenyl) -3,4-dihydro-1H-2-benzothiopyran-4-one-1-carboxamide compound Chemical class 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 230000007062 hydrolysis Effects 0.000 claims 3
- 238000006460 hydrolysis reaction Methods 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 230000009435 amidation Effects 0.000 claims 2
- 238000007112 amidation reaction Methods 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000007254 oxidation reaction Methods 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003018 phosphorus compounds Chemical class 0.000 claims 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/08—Naphthothiopyrans; Hydrogenated naphthothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4021—Esters of aromatic acids (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
- C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655381—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
- C07F9/65539—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Lubricants (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (15)
- 식(Ⅰ)의 황-함유 헤테로 고리 화합물 또는 약학적으로 허용 가능한 그의 염36-1[상기식에서, 고리 A는 치환 가능한 벤젠고리이며, R은 수소 원자 또는 치환 가능한 탄화수소기이고, B는 에스테르화 또는 아미드화 가능한 카르복실기이며, X는 -CH(OH)- 또는 -CO-이고, k는 0 또는 1이며, k'은 0. 1 또는 2이다]
- 제1항에 있어서, 고리 A가 할로겐, C1~10 알킬 및 C1~6알콕시로 구성된 군으로 부터 선택된, 동일하거나 상이한. 1 또는 2개의 치환체에 의해 치환 가능한 벤젠고리인 화합물.
- 제1항에 있어서, 고리 A가 동일하거나 상이한, 1 또는 2개의 C1~10알킬기에 의해 치환가능한 벤젠 고리인 화합물.
- 제1항에 있어서, 고리 A가 C3~7시클로알킬기에 의해 치환가능한 벤젠고리인 화합물.
- 제1항에 있어서, R이 수소원자, C1~10알킬 또는 페닐기인 화합물.
- 제1항에 있어서, R이 수소원자 또는 메틸기인 화합물.
- 제1항에 있어서, B가 C1~10알콕시카르보닐기 또는 식 -CONR1R2의 기(식중, R1및 R2각각은 수소원자,치환가능한 탄화수소기 또는 치환가능한 5- 내지 7-원소로 된 헤테로고리기이다.)인 화합물.
- 제1항에 있어서, B가 식 -CONR1R2의 기(식중, R1및 R2각각은 수소원자, 치환가능한 탄화수소기 또는 치환가능한 5- 내지 7-원소로된 헤테로고리기 이다.)인 화합물.
- 제8항에 있어서, R1이 수소원자이며 R2가 식 -C6H5(CH2)nP(0)(OR')2의 기(식중, n은 0 또는 1이며 R'은 C1~6알킬기 이다.)인 화합물.
- 제1항에 있어서, 고리 A가 할로겐, C1~10알킬 및 C1~6알콕시로 구성된 군으로 부터 선택된, 동일하거나 상이한, 1 또는 2개의 치환체에 의해 치환 가능한 벤젠고리이며, R은 수소원자, C1~10알킬 또는 페닐기이며, B는 C1~10 알콕시카르보닐기 또는 식 -CONR1R2의 기(식중, R1및 R2각각은 수소원자, 치환가능한 탄화수소기 또는 치환가능한 5- 내지 7-원소로된 헤테로 고리기 이다.)이고, k 및 k'은 각각 0인 화합물.
- 제1항에 있어서, 6-시클로헥실-N-(4-디에톡시포스포릴메틸페닐)-3,4-디히드로-1H-2-벤조티오피란-4-온-1-카르복사미드라고 명명되는 화합물.
- 제1항에 있어서, 6,7-디멜틸-N-(4-디에톡시포스포릴페닐)-3,4-디히도로-1H-2-벤조티오피란-4-온-1-키르복사미드라고 명명되는 화합물.
- 제1항에 있어서, 6,7-디메틸-N-(4-디에톡시포스포릴메틸페닐)-3,4-디히드로- 1H-2-벤조티오피란-4-온-1-카르복사미드라고 명명되는 화합물.
- (1)하기 일반식(Ⅱ)의 화합물 또는 그의 염을 고리화 반응시키고, 필요한 경우, 산화 또는/및 가수분해, 가수분해후 아미드화, 또는 가수분해후 아미드화 및 산화반응을 더 수행하여 하기 일반식(Ⅰa)의 황-함유 헤테로고리 화합물 또는 그의 염을 제조하거나, 또는 (2)하기 일반식(Ⅰa)의 화합물 또는 그의 염을 환원시켜 하기 일반식(Ⅰb)의 황-함유 헤테로고리 화합물 또는 그의 염을 제조함을 특징으로 하는 하기 일반식(Ⅰ)의 황-함유 헤테로고리 화합물 또는 그의 염의 제조방법[상기식에서, B'은 에스테르화 카르복실기이며, B는 에스테르화 또는 아미드화 가능한 카르복실기이고, Y는 히도록시기 또는 할로겐 원자이며, X는 -CH(OH)- 또는 -CO-이고, 고리 A는 치환 가능한 벤젠고리이며, R은 수소원자 또는 치환가능한 탄화수소기이고, k는 0 또는 1이며, k'은 0.1 또는 2이다.]
- 유효량의 하기 일반식(Ⅰ)의 항-골다공성 화합물 또는 약학적으로 허용 가능한 염 및 약학적으로 허용가능한 담체 또는 희석제를 함유하는, 골다공증 치료에 사용하는 약학제제.[상기식에서, 고리 A는 치환 가능한 벤젠 고리이며, R은 수소원자 또는 치환 가능한 탄화수소기이고, B는 에스테르화 또는 아미드화 가능한 카르복실기이며, X는 -CH(OH)- 또는 -CO-이고, k는 0 또는 1이며, k'은 0.1 또는 2이다.]※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33524088 | 1988-12-28 | ||
JP88-335240 | 1988-12-28 | ||
JP89-303603 | 1989-11-21 | ||
JP30360389 | 1989-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900009624A true KR900009624A (ko) | 1990-07-05 |
KR0142429B1 KR0142429B1 (ko) | 1998-06-01 |
Family
ID=26563567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890019906A KR0142429B1 (ko) | 1988-12-28 | 1989-12-28 | 황-함유 헤테로고리화합물 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5071841A (ko) |
EP (1) | EP0376197B1 (ko) |
JP (1) | JP2924033B2 (ko) |
KR (1) | KR0142429B1 (ko) |
CN (1) | CN1032470C (ko) |
AT (1) | ATE112770T1 (ko) |
AU (1) | AU623722B2 (ko) |
CA (1) | CA2006723C (ko) |
DE (1) | DE68918827T2 (ko) |
DK (1) | DK656789A (ko) |
ES (1) | ES2060735T3 (ko) |
FI (1) | FI102896B1 (ko) |
HK (1) | HK17396A (ko) |
HU (1) | HU209453B (ko) |
NO (1) | NO179977C (ko) |
NZ (1) | NZ231939A (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5158943A (en) * | 1988-11-21 | 1992-10-27 | Takeda Chemical Industries, Ltd. | Sulfur-containing heterocyclic compounds |
EP0460488B1 (en) * | 1990-05-30 | 2001-07-11 | Takeda Chemical Industries, Ltd. | Sulfur-containing heterocyclic compounds |
EP0769015B1 (en) * | 1994-07-04 | 2001-03-14 | Takeda Chemical Industries, Ltd. | Phosphonic acid compounds, their production and use |
TW403757B (en) | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
US5910492A (en) * | 1995-06-05 | 1999-06-08 | Takeda Chemical Industries, Ltd. | Osteogenic promoting pharmaceutical composition |
CA2226317A1 (en) * | 1995-07-24 | 1997-02-06 | Takeda Chemical Industries, Ltd. | Production of optically active benzothiepin salts |
ID18079A (id) | 1996-08-26 | 1998-02-26 | Takeda Chemical Industries Ltd | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis |
CA2267930A1 (en) * | 1996-10-09 | 1998-04-16 | Nobuyuki Takechi | A method for producing a microparticle |
CA2287228A1 (en) | 1997-04-24 | 1998-10-29 | Tetsuo Hoshino | Apatite-coated solid composition |
CA2334815A1 (en) * | 1998-06-15 | 1999-12-23 | Haruhiko Makino | Composition for treating cartilage disease |
US6355672B1 (en) | 1998-08-07 | 2002-03-12 | Takeda Chemical Industries, Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
TW557298B (en) * | 2000-08-14 | 2003-10-11 | Ciba Sc Holding Ag | A compound, a photopolymerizible composition, a process for producing coatings and a method for causing a photoinitiator to accumulate at the surface of coatings |
EP1324994A4 (en) * | 2000-10-10 | 2004-06-16 | Calyx Therapeutics Inc | TRICYCLIC COMPOUNDS AND USES THEREOF |
CA2637194A1 (en) | 2006-01-18 | 2007-07-26 | National University Corporation Tokyo Medical And Dental University | Biomaterial for osteogenesis containing osteogenesis promoter and nanogel |
KR101613745B1 (ko) | 2008-02-29 | 2016-04-19 | 닛산 가가쿠 고교 가부시키 가이샤 | 티오펜 화합물 및 그 중간체의 제조 방법 |
TWI594975B (zh) | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
ES2864277T3 (es) | 2014-09-26 | 2021-10-13 | Daiichi Sankyo Co Ltd | Sal de compuestos de ácido dicarboxílico |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1935685A1 (de) * | 1969-07-10 | 1971-01-14 | Schering Ag | Neue antimikrobiell wirksame Verbindungen |
US3636049A (en) * | 1969-11-26 | 1972-01-18 | Pfizer | Isothiochroman carboxamides |
FR2621038B1 (fr) * | 1987-09-28 | 1989-12-29 | Rhone Poulenc Sante | Derives d'alcadienes, leurs preparations, les medicaments les contenant et produits intermediaires |
-
1989
- 1989-12-21 NZ NZ231939A patent/NZ231939A/xx unknown
- 1989-12-21 DK DK656789A patent/DK656789A/da not_active Application Discontinuation
- 1989-12-22 AT AT89123794T patent/ATE112770T1/de not_active IP Right Cessation
- 1989-12-22 DE DE68918827T patent/DE68918827T2/de not_active Expired - Fee Related
- 1989-12-22 ES ES89123794T patent/ES2060735T3/es not_active Expired - Lifetime
- 1989-12-22 EP EP89123794A patent/EP0376197B1/en not_active Expired - Lifetime
- 1989-12-27 JP JP1342280A patent/JP2924033B2/ja not_active Expired - Fee Related
- 1989-12-27 FI FI896289A patent/FI102896B1/fi not_active IP Right Cessation
- 1989-12-27 CA CA002006723A patent/CA2006723C/en not_active Expired - Fee Related
- 1989-12-27 HU HU896790A patent/HU209453B/hu not_active IP Right Cessation
- 1989-12-27 NO NO895267A patent/NO179977C/no not_active IP Right Cessation
- 1989-12-28 CN CN89109626A patent/CN1032470C/zh not_active Expired - Fee Related
- 1989-12-28 US US07/458,094 patent/US5071841A/en not_active Expired - Lifetime
- 1989-12-28 AU AU47320/89A patent/AU623722B2/en not_active Ceased
- 1989-12-28 KR KR1019890019906A patent/KR0142429B1/ko not_active IP Right Cessation
-
1996
- 1996-02-01 HK HK17396A patent/HK17396A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI102896B (fi) | 1999-03-15 |
DE68918827D1 (de) | 1994-11-17 |
ES2060735T3 (es) | 1994-12-01 |
EP0376197B1 (en) | 1994-10-12 |
CN1045106A (zh) | 1990-09-05 |
ATE112770T1 (de) | 1994-10-15 |
FI102896B1 (fi) | 1999-03-15 |
CN1032470C (zh) | 1996-08-07 |
HU896790D0 (en) | 1990-03-28 |
FI896289A0 (fi) | 1989-12-27 |
AU623722B2 (en) | 1992-05-21 |
DK656789A (da) | 1990-06-29 |
CA2006723A1 (en) | 1990-06-28 |
DK656789D0 (da) | 1989-12-21 |
HK17396A (en) | 1996-02-09 |
AU4732089A (en) | 1990-07-19 |
NZ231939A (en) | 1991-07-26 |
DE68918827T2 (de) | 1995-02-16 |
NO895267D0 (no) | 1989-12-27 |
NO895267L (no) | 1990-06-29 |
JP2924033B2 (ja) | 1999-07-26 |
CA2006723C (en) | 1998-08-25 |
NO179977C (no) | 1997-01-22 |
KR0142429B1 (ko) | 1998-06-01 |
US5071841A (en) | 1991-12-10 |
EP0376197A1 (en) | 1990-07-04 |
NO179977B (no) | 1996-10-14 |
JPH03232880A (ja) | 1991-10-16 |
HU209453B (en) | 1994-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900009624A (ko) | 황-함유 헤테로 고리 화합물 | |
MY129970A (en) | Hypolipidaemic compounds | |
KR880001583A (ko) | 광학적 활성 벤젠설폰아미드 유도체의 제조방법 | |
ES2000604A6 (es) | Un procedimiento para preparar aril-piperidin esteres | |
DE3767351D1 (de) | Sialosylceramide und verfahren zu deren herstellung. | |
ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
DE69324854D1 (de) | Pyridazinone-Derivate und Verfahren zur deren Herstellung | |
CA2261098A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
KR880005138A (ko) | 신규 화합물들 | |
HRP20000027B1 (en) | Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds | |
FI93455B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1-oksa-2-okso-8-atsaspiro/4,5/dekaanijohdannaisten valmistamiseksi | |
DK141282A (da) | Fremgangsmaade til fremstilling af morpholiner | |
KR960700252A (ko) | 퀴놀린카르복실산 유도체 및 이의 제조방법(quinolinecarboxylic acid derivative and process for producing the same) | |
ATE122683T1 (de) | Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b. | |
SE8406046D0 (sv) | New azabiocyclic compounds and a process for the preparation thereof | |
DE60000375D1 (de) | Verfahren zur Herstellung von Difluoracetophenon-Derivaten | |
DE68926016D1 (de) | Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung | |
DK54180A (da) | Fremgangsmaade til fremstilling af xanthonderivater | |
ATE90101T1 (de) | Verfahren zur herstellung von makrolid-derivaten. | |
DK0455899T3 (da) | Prostaglandin I-analog | |
AU5977980A (en) | Aminodeoxyclavulanic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020320 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |